SAMU
COGT icon

SONA Asset Management (US)’s Cogent Biosciences COGT Stock Holding History

SONA Asset Management (US)’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.08M Sell
80,000
-25,000
-24% -$923K 0.06% 156
2025
Q4 		$3.73M Buy
+105,000
New +$2.95M 0.08% 95

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

SONA Asset Management (US)'s COGT Position: Q1 2026 in Review

SONA Asset Management (US) reduced its Cogent Biosciences (COGT) stake by 24% in Q1 2026, selling an estimated $923K and leaving 80,000 shares worth $3.08M. The position accounts for 0.06% of the portfolio, ranked #156.

SONA Asset Management (US) first reported a position in COGT in Q4 2025 and has held it in 2 quarters since. The position peaked at $3.73M in Q4 2025. 305 funds tracked by Wall St. Rank hold COGT as of Q1 2026.

  • SONA Asset Management (US) held 80,000 shares of Cogent Biosciences worth $3.08M as of Q1 2026.
  • SONA Asset Management (US) sold 25,000 Cogent Biosciences shares in Q1 2026, an estimated $923K.
  • Cogent Biosciences made up 0.06% of SONA Asset Management (US)'s portfolio in Q1 2026, its #156 holding.
  • SONA Asset Management (US) first reported a position in Cogent Biosciences in Q4 2025 and has held it in 2 quarters since.
  • SONA Asset Management (US)'s Cogent Biosciences position peaked at $3.73M in Q4 2025.
  • 305 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2026.

Based on SONA Asset Management (US)'s 13F filing for Q1 2026, filed 15 May 2026.